CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine
Keun-Wook Lee, Bum Jun Kim, Mi-Jung Kim, Hye Sook Han, Jin Won Kim, Young Iee Park, Sook Ryun Park
Cancer Research and Treatment. 2017;49(3):706-716.   Published online 2016 October 18    DOI: https://doi.org/10.4143/crt.2016.216

Excel Download

2300 A multicenter randomized phase II study of docetaxel vs. docetaxel plus cisplatin vs. docetaxel plus S-1 as second-line chemotherapy in metastatic gastric cancer patients who had progressed after cisplatin plus either S-1 or capecitabine
B. Kim, K.W. Lee, M.J. Kim, H.S. Han, Y.L. Park, S.R. Park
European Journal of Cancer. 2015;51:S432   Crossref logo
Link1 Link2
A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine
Keun-Wook Lee, Bum Jun Kim, Mi-Jung Kim, Hye Sook Han, Jin Won Kim, Young Iee Park, Sook Ryun Park
Cancer Research and Treatment. 2017;49(3):706-716   Crossref logo
Link1 Link2 Link3
221O Induction chemotherapy regimen of docetaxel plus cisplatin vs docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of a phase III multicenter randomized controlled trial
S. He, Y. Wang, C. Wang, Z. Peng, Y. Chen
Annals of Oncology. 2022;33:S1521   Crossref logo
Link1 Link2
Docetaxel + Cisplatin (DC) and Docetaxel + Carboplatin (DCb) vs Vinorelbine + Cisplatin (VC) in chemotherapy-naïve patients with advanced and metastatic non-small cell lung cancer (NSCLC): Results of a multicenter, randomized phase III study
F. Fossella
European Journal of Cancer. 2001;37:S154   Crossref logo
Link1 Link2
Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
Deguo Yu, Zhenfeng Wang, Tingbang He, Lijun Yang
Frontiers in Surgery. 2022;9:   Crossref logo
Link1
Docetaxel plus cisplatin versus docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trial
V. Georgoulias, E. Papadakis, A. Alexopoulos, E. Stavrinidis, E. Bania, A. Rapti, Th. Grigoratou, Ch. Kouroussis, S. Kakolyris, G. Samonis
European Journal of Cancer. 1999;35:S249   Crossref logo
Link1 Link2
A multicenter, randomized phase III study of docetaxel + cisplatin (DC) vs docetaxel + carboplatin (DCb) vs vinorelbine + cisplatin (VC) in chemotherapy-naive patients (Pts) with advanced and metastatic non-small cell lung cancer (NSCLC)
C.P Belani, J Rodriguez, J von Pawel, A Pluzanska, V Gorbounova, M Millward, L Bosquée, Y Kim, F Gamza, J Berille, L Hammershaimb, F Fossella
Lung Cancer. 2000;29(1):60   Crossref logo
Link1 Link2
Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study
G. Rosati, D. Bilancia, D. Germano, A. Dinota, R. Romano, G. Reggiardo, L. Manzione
Annals of Oncology. 2007;18:vi128-vi132   Crossref logo
Link1 Link2 Link3
Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: a phase II study
Takashi Seto, Yoriko Takezako, Hiroko Nakamura, Kayo Takeda, Fumiko Inoue, Hiroshi Semba, Kenji Eguchi
International Journal of Clinical Oncology. 2004;9(5):378-382   Crossref logo
Link1 Link2 Link3
Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer
A.D. Seidman
Breast Diseases: A Year Book Quarterly. 2010;21(1):74-76   Crossref logo
Link1 Link2
This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.